Medchemica

<< Back to companies search

 

At the heart of MedChemica Limited is the SALTMINERTM consortium. The company works with sets of data from large pharmaceutical companies and extracts the pre-competitive knowledge of how to design drugs, and combines these into a large database, which all the members of the consortium use. The resulting design rules are then applied to current projects to reduce cycle times by pinpointing chemical changes that have a high probability of fixing issues.

 

MedChemica also makes this knowledge available, through on-line computational tools, to bio-techs, Universities and smaller players in the life sciences industry. Interactions with these organisations are often vibrant and stimulating. As a start-up business, the company has many ideas of how to maximize this knowledgebase to aid the design of better smaller molecules to treat all diseases.

 

MedChemica has experience in a broad range of disease areas including anti-infectives, oncology, cardiovascular and metabolic. We have over 130 publications and patents and have been part of programs producing clinical candidates.

 

MedChemica also offers bespoke medicinal and computational chemistry services, including HTS analysis and Hit selection, Virtual screening, Pharmacokinetic / Non potency analysis, Chem-informatics and Quantum mechanical calculations and modeling.

 

We have collaborations in drug hunting programs and have recently formed Quodrium Limited. This is a joint venture with BlueBerry Therapeutics, SYNthesis Med Chem and Public Health England to explore anti-infective research both as a CRO to run a project for a client and in house research. In this way we have combined our technologies to provide solutions for drug hunting.
At the heart of MedChemica Limited is the SALTMINERTM consortium. The company works with sets of data from large pharmaceutical companies and extracts the pre-competitive knowledge of how to design drugs, and combines these into a large database, which all the members of the consortium use. The resulting design rules are then applied to current projects to reduce cycle times by pinpointing chemical changes that have a high probability of fixing issues.

 

MedChemica also makes this knowledge available, through on-line computational tools, to bio-techs, Universities and smaller players in the life sciences industry. Interactions with these organisations are often vibrant and stimulating. As a start-up business, the company has many ideas of how to maximize this knowledgebase to aid the design of better smaller molecules to treat all diseases.

 

MedChemica has experience in a broad range of disease areas including anti-infectives, oncology, cardiovascular and metabolic. We have over 130 publications and patents and have been part of programs producing clinical candidates.

 

MedChemica also offers bespoke medicinal and computational chemistry services, including HTS analysis and Hit selection, Virtual screening, Pharmacokinetic / Non potency analysis, Chem-informatics and Quantum mechanical calculations and modeling.

 

We have collaborations in drug hunting programs and have recently formed Quodrium Limited. This is a joint venture with BlueBerry Therapeutics, SYNthesis Med Chem and Public Health England to explore anti-infective research both as a CRO to run a project for a client and in house research. In this way we have combined our technologies to provide solutions for drug hunting.

 

 

X
X
X